Gangolli Julian S - Insider Non-Derivative Transactions at Krystal Biotech, Inc. (KRYS) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on May 20, 2024, Gangolli Julian S's relationship to Krystal Biotech, Inc. (KRYS) is Director, and currently has 20,000 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other KRYS insiders.
Data Source: SEC.
Gangolli Julian S - Insider Non-Derivative Transactions at KRYS
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| May 21, 2024 | Sell -- (Common Stock) | 1980 | 165.76 | 0 |
| May 21, 2024 | Sell -- (Common Stock) | 7090 | 164.34 | 1980 |
| May 21, 2024 | Sell -- (Common Stock) | 10930 | 163.71 | 9070 |
| May 21, 2024 | M -- (Common Stock) | 20000 | 22.75 | 20000 |